documents: FDA-2019-N-3065-0763
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-3065-0763 | FDA | FDA-2019-N-3065 | Reference 168 - Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease, 2017 | Supporting & Related Material | Background Material | 2020-03-18T04:00:00Z | 2020 | 3 | 2020-03-18T14:32:50Z | 0 | 0 | 090000648444c7e8 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref